Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Not applicable Interventional

Canine-Assisted ANxiety Reduction IN Emergency Care IV

ClinicalTrials.gov ID: NCT04287452

Public ClinicalTrials.gov record NCT04287452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 1:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Canine-Assisted ANxiety Reduction IN Emergency Care IV (CANINE IV)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Prior literature demonstrates that human stress can be reduced with exposure to animals. This study challenges current dogma by introducing a widely available, low cost method of dog therapy to reduce patient and provider stress. The objectives of this study are to determine if interaction with a certified therapy dog and handler can; * decrease reported anxiety levels in emergency department (ED) patients, * decrease salivary cortisol in ED patients, * decrease total morphine equivalent dosing in the emergency department or at discharge and/or, * decrease reported stress levels in emergency department providers caring for participating patients when compared to usual care.

Study identification

NCT ID
NCT04287452
Recruitment status
Withdrawn
Study type
Interventional
Phase
Not applicable
Lead sponsor
Indiana University
Other
Enrollment
Not listed

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2022
Primary completion
Dec 30, 2022
Completion
Dec 30, 2022
Last update posted
Jul 19, 2023

2022

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Eskenazi Health System Indianapolis Indiana 46202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04287452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2023 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04287452 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →